Elucidating the Phase I metabolism of psilocin in vitro.
Archives of Toxicology March 1, 2025 Junqi Chen, Ziteng Wang, Ching Yee Yong et al. 3 citations
Psilocin is a well-studied controlled substance with potential psychotherapeutic applications. However, research gaps remain regarding its metabolism. Our objective was to elucidate a comprehensive Phase I metabolic profile of psilocin to support its forensic management and clinical development. We utilized human enzymes from various sources to characterize the Phase I metabolism of psilocin...
DOI: 10.1007/s00204-024-03952-7 (opens in new tab)
Full text (opens in new tab)
Psilocin
Psilocybin
Metabolic pathways
Biotransformation
+6